Stay updated on iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T20:39:33.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No user-facing content or study information appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:17:59.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1; no substantive study details, outcomes, or eligibility information appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T17:24:00.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle, updates the QC label from 'Last Update' to 'Last Update Submitted that Met QC Criteria', standardizes the No FEAR Act Data wording, and updates the revision from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-29T06:52:59.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4; no substantive study content appears to be changed.
    Difference
    0.1%
    Check dated 2026-01-15T02:43:19.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now displays a new footer revision tag 'Revision: v3.3.3'. The previous 'Revision: v3.3.2' tag and the 'HHS Vulnerability Disclosure' link were removed.
    Difference
    0.1%
    Check dated 2025-12-24T15:13:47.000Z thumbnail image

Stay in the know with updates to iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.